Tag: ACC 2017
ACC 2017: Dual anti-thrombotic approach has similar risk of bleeding to dual antiplatelet therapy
The GEMINI-ACS study, which was simultaneously presented at the 2017 scientific sessions of the ...
Viagra may reduce cardiovascular outcomes after a first myocardial infarction
Daniel P Andersson (Department of Medicine, Karolinska Institutet, Unit of Endocrinology, Metabo...
ACC 2017: Meta-analysis supports use of RenalGuard in cardiovascular Interventional procedures
A new meta-analysis presented this week at the American College of Cardiology 66th Scientific Se...
ACC 2017: FDA approves launch of CoreValve Evolut Pro
The FDA has approved Medtronic’s CoreValve Evolut Pro transcatheter aortic valve implantation (T...
ACC 2017: Positive final results from ORION-1 phase II study of inclisiran
The Medicines Company and Alnylam Pharmaceuticals have announced positive final results from the ORI...
ACC 2017: TAVI Linked with bleeding in the brain and neurological impairment
Of 84 older patients undergoing transcatheter aortic valve implantationt (TAVI), nearly a quarte...
ACC 2017: Embol-X and CardioGard do not reduce number of brain lesions, but may affect lesion size
Two US Food and Drug Administration-cleared medical devices designed to remove potential vessel-bloc...
ACC 2017: “iFR may be the new standard” of physiological assessment of coronary lesions
Writing in The New England Journal of Medicine, Deepak L Bhatt (Brigham and Women’s Hospital and...
ACC 2017: Mary Norine Walsh assumes American College of Cardiology presidency
Mary Norine Walsh has become president of the American College of Cardiology during the Convocat...
ACC 2017: Wrist-worn heart rate monitors less accurate than standard chest strap
Researchers at Cleveland Clinic, Cleveland, USA, put five popular wrist-worn fitness trackers to the...
ACC 2017: Researchers sound alarm over Zika’s potentially harmful effects on heart
As the Zika virus continues to spread globally, new evidence has emerged about the virus’s poten...
ACC 2017: CardioMEMS HF system effective in reducing heart failure hospitalisations and cost of care
Late-breaking clinical research presented at the American College of Cardiology 66th Annual Scie...
ACC 2017: PCSK9 inhibitor evolocumab significantly reduces the risk of cardiovascular events
Data for a new drug that inhibits proprotein convertase subtilisin-kexin type 9 (PCSK9) show tha...
ACC 2017: Two-year rate of target lesion failure significantly higher with Absorb
Two-year data from the ABSORB III study indicate that a bioresorbable vascular scaffold (Absorb,...
ACC 2017: No significant differences in two-year morality between bicuspid and tricuspid aortic stenosis patients undergoing TAVI
Sung-Han Yoon (Cedars-Sinai Heart Institute, Los Angeles, USA) and others report in the Journal ...
ACC 2017: CoreValve non-inferior to surgery in intermediate-risk patients
Results from the SURTAVI clinical trial, which were presented today at the 2017 scientific sessi...
